Cat. No. | Product name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T19489 | O-Desmethyl gefitinib D8 | T19489 | 98% |
|
O-Desmethyl gefitinib D8 is a deuterium labeled O-Desmethyl gefitinib that is an active metabolite of Gefitinib in human plasma. | ||||
T73128 | EGFR-IN-61 | 2890261-81-9 | 98% |
|
EGFR-IN-61 (compound 22a), a potent EGFR kinase inhibitor, exhibits IC50 values of 42 nM for L858R/T790M, 137 nM for L858R/T790M/C797S, and 743 nM for WT. Additi... | ||||
T73165 | EGFR-IN-73 | 2857033-34-0 | 98% |
|
EGFR-IN-73 (Compound 3f) effectively inhibits the prevalent EGFR mutation, EGFR Del19, exhibiting an IC50 value of 119 nM [1]. | ||||
T73995 | EGFR/CSC-IN-1 | 2820447-02-5 | 98% |
|
EGFR/CSC-IN-1 is a dual inhibitor targeting both the epidermal growth factor receptor (EGFR [IC50 10.52 nM]) and cancer stem cells (CSC), with potential applicat... | ||||
T10556 | BKI-1369 | 1951431-22-3 | 98% |
|
BKI-1369 is a bumped kinase inhibitor. BKI-1369 increases hERG-inhibitory activity (IC50:1.52 μM). | ||||
T10433 | Osimertinib dimesylate | 2070014-82-1 | 98% |
|
Osimertinib dimesylate is an irreversible and mutant selective EGFR inhibitor (IC50s: 12 and 1 nM against EGFR L858R and EGFR L858R/T790M). | ||||
T11213L | Epertinib | 908305-13-5 | 98% |
|
Epertinib is a reversible and selective tyrosine kinase inhibitor of EGFR, HER2, and HER4 (IC50s: 1.48 nM, 7.15 nM, and 2.49 nM). It displays a strong antitumor ... | ||||
TN3711 | Corylifol C | 775351-91-2 | 98% |
|
Corylifol C and, to a lesser extent, xanthoangelol are potent protein kinase inhibitors (inhibitory concentration 50% values for epidermal growth factor receptor... | ||||
T16362 | Nuvenzepine | 96487-37-5 | 98% |
|
Nuvenzepine is an antagonist of mAChR. It has the potential for gastrospasm treatment. | ||||
TN5100 | Taspine | 602-07-3 | 98% |
|
Taspine shows antitumor activity by modulating the EGFR signaling pathway of Erk1/2 and Akt in vitro and in vivo, it can inhibit growth and induce apoptosis of H... | ||||
TN4213 | Hirsutenone | 41137-87-5 | 98% |
|
Hirsutenone has potent antioxidant activity, it shows significant free radical scavenging activity and exhibits inhibition effect on the mitochondrial lipid pero... | ||||
T12131 | Mutated EGFR-IN-3 | 2375107-27-8 | 98% |
|
Mutated EGFR-IN-3 is a ATP-competitive and highly selective allosteric dibenzodiazepinone EGFR(L858R/T790M) and EGFR(L858R/T790M/C797S) inhibitor(IC50 of 12 nM a... | ||||
T13743 | JH-XI-10-02 | 2209085-22-1 | 98% |
|
JH-XI-10-02 causes proteasomal degradation, does not affect CDK8 mRNA levels. JH-XI-10-02 shows no effect on CDK19. JH-XI-10-02 is a potent and selective degrade... | ||||
TN1912 | Marinobufogenin | 470-42-8 | 98% |
|
Marinobufagenin, a cardiotonic steroid, its increased concentrations are important in the cardiac disease and oxidant stress state seen with renal failure. | ||||
T9922 | Matuzumab | 339186-68-4 | 98% |
Matuzumab
|
Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR frequently associated with the growth of blood vessels in ... | ||||
TN2504 | 1,5-Dihydroxyxanthone | 14686-65-8 | 98% |
|
1,5-Dihydroxyxanthone exhibits the epidermal growth factor receptor (EGFR) -tyrosine kinase inhibitory activity, with the IC50 value of 90.34 nM. It may have ant... | ||||
T12130 | Mutated EGFR-IN-2 | 2050906-97-1 | 98% |
|
Mutated EGFR-IN-2 is an inhibitor of mutant-selective EGFR. | ||||
T11159 | EGFR-IN-2 | 1643497-70-4 | 98% |
|
EGFR-IN-2 is a non-covalent, mutation-selective and irreversible second-generation EGFR inhibitor. | ||||
T8525 | EGFR-IN-16 | 133550-22-8 | 98% |
|
EGFR-IN-16 (AG473) is an inhibitor of EGFR in human A431 cells. | ||||
TN4638 | Neolinine | 112515-37-4 | 98% |
|
Neolinine(at 10uM) shows significant hERG K+ channel inhibition activity. |